tiprankstipranks
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market
Holding GDTC?
Track your performance easily

CytoMed Therapeutics Limited (GDTC) Financial Statements

6 Followers

CytoMed Therapeutics Limited Financial Overview

CytoMed Therapeutics Limited's market cap is currently ―. The company's EPS TTM is $-0.196; its P/E ratio is -11.47; CytoMed Therapeutics Limited is scheduled to report earnings on May 5, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Jun 22Dec 21
Income Statement-
Total Revenue----
Gross Profit----
EBIT----
EBITDA----
Net Income Common Stockholders----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsS$ 9.04MS$ 1.42MS$ 1.49MS$ 2.51M
Total AssetsS$ 12.37MS$ 8.22MS$ 5.15MS$ 6.08M
Total DebtS$ 448.02KS$ 483.25KS$ 3.36MS$ 3.26M
Net DebtS$ -8.59MS$ -934.72KS$ 1.87MS$ 745.93K
Total LiabilitiesS$ 1.12MS$ 7.69MS$ 3.59MS$ 3.49M
Stockholders EquityS$ 11.25MS$ -6.12MS$ 1.56MS$ 2.59M
Cash Flow-
Free Cash Flow----
Operating Cash Flow----
Investing Cash Flow----
Financing Cash Flow----
Currency in SGD

CytoMed Therapeutics Limited Earnings and Revenue History

CytoMed Therapeutics Limited Debt to Assets

CytoMed Therapeutics Limited Cash Flow

CytoMed Therapeutics Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis